1. Home
  2. HST vs DVA Comparison

HST vs DVA Comparison

Compare HST & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Host Hotels & Resorts Inc.

HST

Host Hotels & Resorts Inc.

HOLD

Current Price

$18.36

Market Cap

11.9B

Sector

Real Estate

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$121.50

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HST
DVA
Founded
1927
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Misc Health and Biotechnology Services
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
8.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
HST
DVA
Price
$18.36
$121.50
Analyst Decision
Buy
Hold
Analyst Count
13
4
Target Price
$18.65
$145.00
AVG Volume (30 Days)
7.1M
972.4K
Earning Date
11-05-2025
10-29-2025
Dividend Yield
5.17%
N/A
EPS Growth
3.27
5.63
EPS
1.06
9.76
Revenue
$5,950,000,000.00
$13,317,965,000.00
Revenue This Year
$6.31
$6.50
Revenue Next Year
$1.80
$2.97
P/E Ratio
$17.35
$12.43
Revenue Growth
6.44
5.14
52 Week Low
$12.22
$113.97
52 Week High
$19.03
$179.60

Technical Indicators

Market Signals
Indicator
HST
DVA
Relative Strength Index (RSI) 64.76 54.23
Support Level $17.04 $115.91
Resistance Level $17.69 $122.61
Average True Range (ATR) 0.37 2.30
MACD 0.06 0.54
Stochastic Oscillator 89.42 83.43

Price Performance

Historical Comparison
HST
DVA

About HST Host Hotels & Resorts Inc.

Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: